In The News Posted January 30, 2019 Share Posted January 30, 2019 GAITHERSBURG, Md., Jan. 30, 2019 /PRNewswire/ -- Sirnaomics, Inc., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases, today announced that the management will present and conduct face-to-face meetings at the 2019 ... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.